On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia.

Autor:	Feldman, E. J.1 ejf2001@med.cornell.edu, Cortes, J.2, DeAngelo, D. J.3, Holyoake, T.4, Simonsson, B.5, O'Brien, S. G.6, Reiffers, J.7, Turner, A. R.8, Roboz, G. J.1, Lipton, J. H.9, Maloisel, F.10, Colombat, P.11, Martinelli, G.12, Nielsen, J. L.13, Petersdorf, S.14, Guilhot, F.15, Barker, J.16, Kirschmeier, P.17, Frank, E.17, Statkevich, P.17
Zdroj:	Leukemia (08876924). Sep2008, Vol. 22 Issue 9, p1707-1711. 5p. 4 Charts, 1 Graph.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu